Anixa Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ANIX Nasdaq 2836 www.anixa.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anixa Biosciences, Inc.

Is Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year? - Jul 9th, 2025 7:40 am
Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology - Jul 9th, 2025 6:00 am
ANIXA BIOSCIENCES INC (ANIX) is a Great Momentum Stock: Should You Buy? - Jun 26th, 2025 10:00 am
Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year? - Jun 23rd, 2025 7:40 am
Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial - Jun 23rd, 2025 6:00 am
Anixa Biosciences to Host an Investor Webcast on June 26, 2025 - Jun 20th, 2025 5:30 am
3 Promising Penny Stocks With Market Caps Over $100M - Jun 11th, 2025 12:05 pm
What Makes ANIXA BIOSCIENCES INC (ANIX) a Strong Momentum Stock: Buy Now? - Jun 10th, 2025 10:00 am
Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage - Jun 10th, 2025 5:00 am
Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025 - Jun 9th, 2025 6:00 am
All You Need to Know About Anixa Biosciences (ANIX) Rating Upgrade to Buy - Jun 5th, 2025 10:00 am
Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview - Jun 3rd, 2025 5:25 am
Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine - Jun 2nd, 2025 5:00 am
Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones - May 19th, 2025 6:00 am
Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting - May 12th, 2025 6:00 am
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th - Apr 30th, 2025 6:00 am
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio - Apr 14th, 2025 6:00 am
Is AngioDynamics (ANGO) Outperforming Other Medical Stocks This Year? - Apr 11th, 2025 7:40 am
ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up - Apr 10th, 2025 7:58 am
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology - Apr 9th, 2025 6:00 am